专利检索 ap:("THE JACKSON LABORATORY") AND inv:"Gregory Christianson" 第 1 页

1.

发明申请
ANTIBODIES AND FC FUSION PROTEIN MODIFICATIONS WITH ENHANCED PERSISTENCE OR PHARMACOKINETIC STABILITY IN VIVO AND METHODS OF USE THEREOF 有权

公开(公告)号：US20220242933A1

公开(公告)日：2022-08-04

申请号：US17466247

申请日：2021-09-03

申请人： THE JACKSON LABORATORY

发明人： Derry Roopenian , Gregory Christianson

IPC分类号： C07K16/00 , A61K47/54 , A61K47/68

摘要： In certain embodiments, this present invention provides antibodies and Fc fusion proteins with enhanced pharmacokinetics, such as biotinylated antibodies or biotinylated Fc fusion polypeptides.

2.

发明申请
ANTIBODIES AND FC FUSION PROTEIN MODIFICATIONS WITH ENHANCED PERSISTENCE OR PHARMACOKINETIC STABILITY IN VIVO AND METHODS OF USE THEREOF 审中-公开

公开(公告)号：US20200239548A1

公开(公告)日：2020-07-30

申请号：US16572003

申请日：2019-09-16

申请人： THE JACKSON LABORATORY

发明人： Derry Roopenian , Gregory Christianson

IPC分类号： C07K16/00 , A61K47/54 , A61K47/68 , A61K39/00

摘要： In certain embodiments, this present invention provides antibodies and Fc fusion proteins with enhanced pharmacokinetics, such as biotinylated antibodies or biotinylated Fc fusion polypeptides.

3.

发明授权
Antibodies and Fc fusion protein modifications with enhanced persistence or pharmacokinetic stability in vivo and methods of use thereof 有权

公开(公告)号：US11136377B2

公开(公告)日：2021-10-05

申请号：US16572003

申请日：2019-09-16

申请人： THE JACKSON LABORATORY

发明人： Derry Roopenian , Gregory Christianson

IPC分类号： C07K16/00 , A61K47/54 , A61K47/68 , A61K39/00

摘要： In certain embodiments, this present invention provides antibodies and Fc fusion proteins with enhanced pharmacokinetics, such as biotinylated antibodies or biotinylated Fc fusion polypeptides.